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OBJECTIVE: Colorectal cancer (CRC) and hypodontia are frequent and different diseases with common genes are involved in their
etiology. The objective of this study was to identify the association between AXIN2 rs2240308 with hypodontia and CRC.
PATIENTS AND METHODS: This study consisted of 50 individuals with hypodontia, 50 individuals with CRC, and 155 healthy
individuals from Colombia. SNP genotyping assays of rs2240308 were performed and family history of cancer in individuals with
hypodontia was documented. In silico analysis was implemented to define the genomic profile of the AXIN2 gene associated with
CRC. Multivariate analysis, chi square, odd ratio tests, and R software were used for statistical analysis.
RESULTS: AXIN2 rs2240308 showed association with CRC (OR= 5.4 CI: 2.7–10.4; p < 0.001) and with other familial cancer in
individuals with hypodontia (p < 0.005 OR= 1.75, 95% CI: 1.22–6.91). In silico analysis showed that variations in AXIN2 found in CRC
patients, were more frequently in earlier stages of tumor and patients who carry variations in the AXIN2 gene have a worse
prognosis (p < 0.05). The association between AXIN2 rs2240308 with hypodontia was not significant.
CONCLUSIONS: These results suggest that AXIN2 rs2240308 polymorphism is associated with CRC and AXIN2 could be a risk
marker for predisposition and prognosis of CRC.
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INTRODUCTION
Dental agenesis is one of the most common congenital anomalies
in human dentition. Hypodontia occurs when there are one to five
missing teeth and its prevalence reaches 2.6–11.3% depending
the ethnic group.1 Although the etiology of dental agenesis
involved genetic and environmental factors, the genes more
frequently associated with hypodontia in different populations are
AXIN2, MSX1, PAX9, EDA, and WNT10.2,3
From the study of Lamni et al.,4 many investigations relating
dental agenesis with predisposition to cancer, primarily Colorectal
cancer (CRC), have arisen.5–7 This association is supported by the
molecular events that keep homeostasis of morphogenesis and
tissue regeneration. CRC is the fourth most common cause of
cancer-related deaths in the world 8 and it has been reported that
colorectal carcinogenesis is associated with alterations in Wnt
signaling. Some CRC, like adenomatous polyposis and hereditary
nonpolyposis CRC syndrome (Lynch syndrome), involve mutations
in germline or in repair genes.9 Developmental homeostasis
involves the wingless/integration (WNT) signaling pathway con-
trolling cell proliferation, differentiation, and cell death.10 When
cells receive the WNT signal, β-catenin is stabilized and joins the
DNA-bound T-cell factor family of transcription proteins for
regulating the expression of target genes. In the absence of
WNT, β-catenin protein is degraded by the proteasome via action
of a multiprotein complex. This complex is composed of the tumor
suppressor adenomatous polyposis coli gene product (APC) and
AXIN1 (axis inhibition protein 1) or its homologous protein, AXIN2.
They formed a structure with β-catenin, glycogen synthase kinase
3β (GSK3β), and disheveled (DLV) protein.11 Hence, molecules
such as WNT (WNT4, WNT6, and WNT10) and AXIN2 play an
important role during the embryonic development that involves
dental formation.12
The association between AXIN2 and CRC involves defects in the
canonical WNT signaling pathway, which regulates and coordi-
nates the AXIN complex for the degradation of β-catenin under
normal conditions. In addition, AXIN2 expression can be elevated
in CRC as a result of APC mutations. However, and in an
independent way, alterations in AXIN2 (loss-of-function, dosage
dependent, or even gain-of-function mutations) can contribute to
development of gastric cancer.13
The genetic connection between alterations in embryonic
development of dental organs and predisposition to cancer is
understandable; particularly the finding that AXIN2 mutations
could lead to an inefficient block of the WNT signaling pathway.
Somatic mutations in the AXIN-complex proteins associated with
degradation of β-catenin or mutations in β-catenin have been
found in different tissues with carcinoma, including skin, gastro-
intestinal, hepatocellular, and ovarian epithelial cancer.4,14 In
addition, AXIN2 has also been independently associated with
tooth agenesis and non-syndromic cleft lip palate (NSCLP).15
AXIN2 SNP rs2240308 has been mapped at human chromosome
17q23-q24. This polymorphism (rs2240308, c.148 G > A) results in
an amino acid change from proline to a serine. Although,
rs2240308 has been associated with hypodontia and cancer in
different populations,16,17 in Iranian subjects, this polymorphism
was related with decreased risk for CRC.18 The inconsistent results
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reported in literature are explained by racial differences.17 In
Latino populations, genetic studies relating hypodontia and CRC
are scarce, although AXIN2 rs2240308 was recently associated with
CRC in Mexican population.19 Therefore, identifying and analyzing
genetic mutations in CRC and hypodontia can provide relevant
information about the biological behavior of both diseases. The
aim of this study was to identify the association between AXIN2
rs2240308 with hypodontia and CRC.
MATERIALS AND METHODS
Population sample
The population consisted of individuals who assisted to Dentistry
faculties at Pontificia Universidad Javeriana and Universidad de
Cartagena and adults who underwent surgery for CRC at
gastroenterology private clinic in Bogotá, and Hospital Universi-
tario del Caribe in Cartagena, Colombia. Subjects were selected
randomly from these institutions and population sample was
divided into three groups according to their pathology. A group of
50 subjects with hypodontia, a group of 50 subjects with CRC, and
a control group of 155 healthy individuals from both cities in
Colombia. This observational analytical cross-sectional study was
approved by the Ethical Committees of Dentistry faculty of
Pontificia Universidad Javeriana (CIEFOUJ 201108-7539). Informed
consent was obtained from all subjects participating.
Patients with hypodontia and healthy individuals were exam-
ined at the same clinic by two dentists and patients with CRC were
operated by the single professional. Hypodontia-affected indivi-
duals were in the age range of 18–28 years. Hypodontia diagnosis
was confirmed through complete intraoral examination, panora-
mic radiographies, and clinical records. Subjects with an uncertain
hypodontia diagnosis, syndromes associated with hypodontia,
trauma history, or agenesis of third molars were excluded from the
study. Subjects with CRC were in the age range of 32–64 years.
CRC in all patients was histopathologically confirmed. There was
no restriction on sex, age, or histopathological classification and
states for selection of CRC patients. The control group included
age, sex, and ethnic background matched selected from healthy
individuals in the same area during the same time period as the
case study. The ethnic background was determined by skin
pigmentation and origin of the participants. Subjects with
syndromes, hypodontia, trauma, or any type of cancer were
excluded.
Genotyping
Self-reported family history of cancer and hypodontia was
collected through questionnaire in all participants (control
hypodontia and CRC groups). DNA was obtained from saliva
samples through Oragene® DNA kit (DNA Genonek Inc, Canada).
AXIN2 rs2240308 PCR products were obtained from the samples of
all the individuals enrolled in the study and sent for genotyping to
the Molecular Cloning Laboratories (MCLAB, San Francisco, CA).
In silico analysis
With the aim of defining the genomic profile of AXIN2 in CRC, we
performed an in silico analysis on data obtained from the
web resource cBioPortal. Three comprehensive studies and one
TCGA Provisional study were considered: DFCI, Cell Reports 2016
(n= 619), Genentech, Nature 2012 (n= 276), TCGA, Provisional
(Raw data at the NCI, n= 633), and MSK, Cancer Cell 2018 (n=
1134).20–22 The tools provided by cBioportal and R packages from
Bioconductor were employed for data integrative analysis and
visualization.
For each study, we obtained a network of the most frequently
altered neighboring genes of AXIN2. The number of genes was
filtered according to the percentage of alteration of the neighbor
genes, with a set threshold >2.6%. This threshold was established
in 2.6 because it is the minimum threshold for some altered gene
associated with AXIN2 to appear, at least in the study of Cell
Reports 2016. The same procedure was applied to each study, we
set the lower threshold in order to obtain altered genes related
with AXIN2. To get the overlapping genes between the networks,
Euler Diagram was used. APC was the most redundant gene. For
gene network association and functional enrichment analysis, we
employed the web resources GeneMania (https://genemania.org/)
and Enrichr (http://amp.pharm.mssm.edu/Enrichr/), respectively.
Statistical analysis
The Chi-square, Fisher’s Exact and Odds Ratio (ORs) tests were
calculated to assess associations between variations in AXIN2
rs2240308 with hypodontia and CRC. Multivariate analysis was
employed to identify relationship between familial cancer history
in patients with hypodontia and AXIN2 variations. P < 0.05 was
considered statistically significant. These statistical analyses were
performed with and SPSS version 22.0 (software license Pontificia




The demographic data for the study participants are described in
Table 1. Familial cancer history was higher in patients with
hypodontia compared with the control group showing a statistical
significant difference for AXIN2 rs2240308 (p < 0.005 OR= 1.75,
95% CI: 1.22–6.91). However, Gastric cancer was the most frequent
cancer in relatives of patients with hypodontia. In contrast, only
10% of patients with CRC reported family history of hypodontia
(Table 2).
The observed genotype distribution for the Axin2 rs2240308
polymorphism in all groups, controls, hypodontia, and CRC was in
agreement with the Hardy–Weinberg equilibrium. Statistical
significant association was observed for CRC with AXIN2
rs2240308 (OR= 5.4, 95% CI: 2.7–10.4; p < 0.001). The most
frequent type and stage of CRC in this sample was adenocarci-
noma (68%) and Dukes'B colon cancer (63.4%).
Regarding to hypodontia, there was no significant association
with AXIN2 rs2240308 (p < 0.31). The most frequent tooth agenesis
was observed in upper lateral incisors (40%) followed by
mandibular second premolars (24%). Other teeth with agenesis
were lower lateral incisors, maxillary first premolars, and lower
central incisors (36%).




group (%) n= 50
Control group
(%) n= 155
Age (years) 32–64 18–28 18–64
Sex
Male 37 23 77





























Cartagena is located at Caribbean region and Bogotá is located in central
zone of Colombia
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In silico analysis
The genomic profile of AXIN2 in CRC patients indicates that the
frequency of alteration/mutation of the gene is usually not higher
than 10% of the patients. It is commonly associated with the
alteration of other genes related with the WNT pathway, such as
APC and CTNBB1. Genomic profile for AXIN2 in CRC is shown in
Figs. 1 and 2. Also, there was an association with the tumor
location, being AXIN2 gene more frequently mutated in tumor
samples derived from the right colon than those derived from the
left. Staging and sample type were also evaluated and the group
of AXIN2 mutated showed an association with earlier stages
compared with the other group. Interestingly, overall survival
analysis indicated that patients who carry variations in the AXIN2
gene have a worse prognosis (p < 0.05).
In summary, by data mining analysis we have defined the
genomic profile of AXIN2 gene in CRC. It is altered in 5–10% of
CRC patients, it would be associated with the MSI molecular
subtype and right-side tumors. Moreover, AXIN2 was found more
frequently altered in early-stage tumors compared with
metastatic CRC. However, patients who harbor mutations in
AXIN2 were found to be associated with a worse prognosis.
Along with AXIN2 those patients also showed mutations in WNT
pathway related genes such as APC, RNF43, PIK3CA, among
others. Mutations in these genes, as well the activation of the
WNT pathway, have been primarily associated with Instability
Microsatellite (MSI) molecular subtype right-side CRC tumors. It
is possible that AXIN2 mutation can be a passenger of these
driver genes in MSS tumors, but in turn it could be considered a
driver gene in MSI right-side tumors. The association of AXIN2
mutation with poor prognosis and its appearance in early
stages, position it as a prognostic and predictive marker in the
defined molecular subtype of right-side colorectal tumors with
MSI.23
DISCUSSION
The association between AXIN2 and CRC has been demonstrated
in different populations, but the association between rs2240308
Table 2. Percentage of family history of cancer or hypodontia in all groups (CRC, hypodontia, and control)






CRC 14 10 1.93
Gastric cancer 8 18 3.22
None 46 38 73.55
Other types of cancer (breast, liver, ovarian,
oral, liver, prostatic, lung, brain, kidney)
32 34 21.29
Hypodontia 10 18 2.58
Fig. 1 Genomic profile of AXIN2 in colorectal cancer. a The percentage and number of samples with gene alterations in AXIN2 are shown across
the different datasets included in the analysis. b Gene network analysis of AXIN2 associated genes that are also altered in CRC in at least 2.6 % of
cases. This percentage—at the bottom of each network—represents the minimum alteration frequency of the genes that integrate the network;
below this threshold there are no genes altered associated to AXIN2. c Euler diagram of common genes between the different lists of genes
obtained from the network analysis
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and CRC in Latino American population, it has been previously
reported only in Mexican population.19 The present study showed
a statistically significant association between AXIN2 rs2240308 and
CRC (OR= 5.4 CI: 2.7–10.4; p < 0.001). Latin America has a history
of large admixture between Africans, Europeans, and Native
Americans, for this reason, this region has a high physical and
genetic ancestry variation. The Asian ancestry in Colombia and
Mexico is <1%.24 Significant differences have been reported in the
association between rs2240308 and the risk of cancer for type of
cancer and ethnic group.17 Then, while it has been reported that
rs2240308 increased the risk of lung cancer especially in Asian
population,5 a recent analysis indicated that AXIN2 148 C > T
(rs2240308) variant may be associated with decrease lung risk in
Asian and Caucasian populations.25 Therefore, further studies in
Latin American population should be conducted to explain the
association between AXIN2 polymorphisms and CRC.
Literature about the association of AXIN2 rs2240308 poly-
morphism with cancer show inconsistent results. AXIN2
rs2240308 polymorphism has been mainly associated with
prostate and lung cancer, but its association with ovarian
cancer, head and neck cancer, astrocytoma, and CRC did not
show similar results. Liu et al.30 reported that AXIN2 is
overexpressed in CRC in patients with DNA mismatch repair,
but in this study, they did not report the association with
rs2240308.26 In addition, several studies propose that hypodon-
tia associated with AXIN2 variations could be a risk marker for
CRC.27,28 In contrast, other studies propose Axin2 rs2240308 as a
potential therapeutic target for preventing tumor growth.29 The
possible explanations for these inconsistencies are related with
racial differences observed in these associations26,30–32 or, with
other gene interactions and gene pathways involved in CRC and
in tooth development.33
Other possible explanation could be related with the results
shown in silico analysis. This analysis demonstrated that the
mutation of AXIN2 observed in CRC is usually not higher than
10% of the patients and it is commonly associated with the
Fig. 2 Comprehensive analysis of AXIN2 genomic profile on data from the study of Yaeger et al. a AXIN2 mutated samples in the study of
Cancer Cell 2018, a total of 53 out of the 1099 patients harbored at least one mutation in AXIN2 gene. b Association of clinical variables and
AXIN2 mutated samples. c Kaplan Meier of the overall survival of patients with AXIN2 mutation. d Mutational profile of the most mutated
genes in the AXIN2 mutated patients
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alteration of other genes related with the WNT pathway.
Nonetheless, the most frequently activated signaling in meta-
static CRC is the WNT pathway. For this reason, we performed
additional in silico analysis. This analysis showed that mutations
in AXIN2 found in CRC patients were more frequently in earlier
stages of tumor samples derived from the right colon than those
derived from the left. Furthermore, patients who carry mutations
in the AXIN2 gene have a worse prognosis (p < 0.05). This fact,
remark the importance to identify biomarkers for CRC in
population, such as AXIN2 variations in patients with Hypodon-
tia. However, one limitation of our study is the fact that we could
not document hypodontia in patients with CRC because we did
not have history records of these individuals. Then, we could not
establish if the cause of tooth absence was extraction or
hypodontia.
Our study showed a statistical significant difference between
familial cancer history in individuals with hypodontia and AXIN2
rs2240308 variations (p < 0.005 OR= 1.75, 95% CI: 1.22–6.91).
Gastric cancer was the most frequent cancer in this association.
The association between AXIN2 and gastric cancer has been
reported,34 but the association between hypodontia and gastric
cancer has not been demonstrated.15,35 Predisposition to CRC is
reported with greater frequency in patients with severe oligo-
dontia and it is directly related to the loss of AXIN2 function. In the
same context, dental agenesis had been proposed as a risk marker
related for ovarian epithelial cancer.15,36
According to the results from the present research, upper lateral
incisor was the most frequent missing teeth among patients with
the AXIN2 rs2240308, although these associations were not
statistically significant. In contrast, AXIN2 rs2240308 showed
association with hypodontia in individuals from Brazil who had
at least one missing tooth, although one conclusion of this study
was that dental agenesis arises from multiple AXIN2 gene
variants.37 Mutations in AXIN2 have been mainly associated with
moderate oligodontia which affects incisors and also individuals
with severe oligodontia which is caused by two truncated AXIN2
proteins.4,38
In conclusion, the results of the present study showed an
association between AXIN2 rs2240308 and CRC in Colombian
population. In silico analysis demonstrated that patients who carry
any mutations of AXIN2 have worse prognosis. Future studies
should be performed to identify biomarkers in CRC and its
association with hypodontia and to identify target molecules for
CRC treatment.
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